939 results · 25ms · Sources: EU EUDAMED, US FDA

BIOSCOPE SD TENS, ARISTA SD PLUS, AP-102080T

FDA 510(k)
FDA Class 2 ·Neurology

AEMS V, EMS-1000, MODEL TS-140500 AND AEMS VI, EMS-1000 PLUS, MODEL TS-140600

FDA 510(k)
FDA Class 2 ·Physical Medicine

APEX MEDICAL LCD TENS-VII

FDA 510(k)
FDA Class 2 ·Neurology

ACU-STIM TENS, AP-101082T

FDA 510(k)
FDA Class 2 ·Neurology

BESTNEB PORTABLE AEROSOL THERAPY UNIT, AP-100100

FDA 510(k)
FDA Class 2 ·Anesthesiology

MODIFICATION TO:APEX MEDICAL IF-4100

FDA 510(k)
FDA Class 2 ·Neurology

COM-PATCH

FDA 510(k)
FDA Class 2 ·Neurology

MS104A, NEWMINI II (EMS-II), MODEL AP-101050T AND MEDTRIM (EMS-V), MODEL AP-102050T

FDA 510(k)
FDA Class 2 ·Physical Medicine

Geonic Nasal Aspirator, Geonic Nasal Cleaner

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

APEX MEDICAL DIGITAL TENS TS1211, TS1212

FDA 510(k)
FDA Class 2 ·Neurology

APEX MEDICAL DIGITAL EMS TS1311, TS1312

FDA 510(k)
FDA Class 2 ·Physical Medicine

MICRO II MICROCURRENT TENS

FDA 510(k)
FDA Class 2 ·Neurology

Algesimeter, Powered

FDA classification
FDA Class 2 ·Algesimeter, Powered

Detector And Alarm, Arrhythmia

FDA classification
FDA Class 2 ·Detector And Alarm, Arrhythmia

Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

FDA classification
FDA Class 2 ·Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA classification
FDA Class 2 ·Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization

FDA classification
FDA Class 2 ·Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization

Early Growth Response 1 (Egr) Fish Probe Kit

FDA classification
FDA Class 2 ·Early Growth Response 1 (Egr) Fish Probe Kit

Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers

FDA classification
FDA Class 2 ·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers